Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose

Tae Sik Nam, Hoon Choi Sung, So Young Rah, Seon Young Kim, Won Jang, Mie Jae Im, Ho Jeong Kwon, Uh Hyun Kim

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR), from β-NAD+. A prototype of mammalian ADPR-cyclases is a lymphocyte antigen CD38. Accumulating evidence indicates that ADPR-cyclases other than CD38 are expressed in various cells and organs. In this study, we discovered a small molecule inhibitor of kidney ADPR-cyclase. This compound inhibited kidney ADPR-cyclase activity but not CD38, spleen, heart or brain ADPR-cyclase activity in vitro. Characterization of the compound in a cell-based system revealed that an extracellular calcium-sensing receptor (CaSR)-mediated cADPR production and a later long-lasting increase in intracellular Ca2+ concentration ([Ca2+]i) in mouse mesangial cells were inhibited by the pre-treatment with this compound. In contrast, the compound did not block CD3/TCR-induced cADPR production and the increase of [Ca2+] i in Jurkat T cells, which express CD38 exclusively. The long-lasting Ca2+ signal generated by both receptors was inhibited by pre-treatment with an antagonistic cADPR derivative, 8-Br-cADPR, indicating that the Ca2+ signal is mediated by the ADPR-cyclse metabolite, cADPR. Moreover, among structurally similar compounds tested, the compound inhibited most potently the cADPR production and Ca2+ signal induced by CaSR. These findings provide evidence for existence of a distinct ADPR-cyclase in the kidney and basis for the development of tissue specific inhibitors.

Original languageEnglish
Pages (from-to)718-725
Number of pages8
JournalExperimental and Molecular Medicine
Volume38
Issue number6
Publication statusPublished - 2006 Dec 31

Fingerprint

ADP-ribosyl Cyclase
Cyclic ADP-Ribose
Calcium
Kidney
Molecules
CD38 Antigens
Calcium-Sensing Receptors
Jurkat Cells
Mesangial Cells
T-cells
Lymphocytes
Second Messenger Systems
Metabolites
NAD
Brain
Spleen
Tissue
Derivatives
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Nam, Tae Sik ; Sung, Hoon Choi ; Rah, So Young ; Kim, Seon Young ; Jang, Won ; Im, Mie Jae ; Kwon, Ho Jeong ; Kim, Uh Hyun. / Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase : Implication for intracellular calcium signal mediated by cyclic ADP-ribose. In: Experimental and Molecular Medicine. 2006 ; Vol. 38, No. 6. pp. 718-725.
@article{55dcfe9ca01b4eddb450a3293ac798d7,
title = "Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose",
abstract = "ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR), from β-NAD+. A prototype of mammalian ADPR-cyclases is a lymphocyte antigen CD38. Accumulating evidence indicates that ADPR-cyclases other than CD38 are expressed in various cells and organs. In this study, we discovered a small molecule inhibitor of kidney ADPR-cyclase. This compound inhibited kidney ADPR-cyclase activity but not CD38, spleen, heart or brain ADPR-cyclase activity in vitro. Characterization of the compound in a cell-based system revealed that an extracellular calcium-sensing receptor (CaSR)-mediated cADPR production and a later long-lasting increase in intracellular Ca2+ concentration ([Ca2+]i) in mouse mesangial cells were inhibited by the pre-treatment with this compound. In contrast, the compound did not block CD3/TCR-induced cADPR production and the increase of [Ca2+] i in Jurkat T cells, which express CD38 exclusively. The long-lasting Ca2+ signal generated by both receptors was inhibited by pre-treatment with an antagonistic cADPR derivative, 8-Br-cADPR, indicating that the Ca2+ signal is mediated by the ADPR-cyclse metabolite, cADPR. Moreover, among structurally similar compounds tested, the compound inhibited most potently the cADPR production and Ca2+ signal induced by CaSR. These findings provide evidence for existence of a distinct ADPR-cyclase in the kidney and basis for the development of tissue specific inhibitors.",
author = "Nam, {Tae Sik} and Sung, {Hoon Choi} and Rah, {So Young} and Kim, {Seon Young} and Won Jang and Im, {Mie Jae} and Kwon, {Ho Jeong} and Kim, {Uh Hyun}",
year = "2006",
month = "12",
day = "31",
language = "English",
volume = "38",
pages = "718--725",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "6",

}

Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase : Implication for intracellular calcium signal mediated by cyclic ADP-ribose. / Nam, Tae Sik; Sung, Hoon Choi; Rah, So Young; Kim, Seon Young; Jang, Won; Im, Mie Jae; Kwon, Ho Jeong; Kim, Uh Hyun.

In: Experimental and Molecular Medicine, Vol. 38, No. 6, 31.12.2006, p. 718-725.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase

T2 - Implication for intracellular calcium signal mediated by cyclic ADP-ribose

AU - Nam, Tae Sik

AU - Sung, Hoon Choi

AU - Rah, So Young

AU - Kim, Seon Young

AU - Jang, Won

AU - Im, Mie Jae

AU - Kwon, Ho Jeong

AU - Kim, Uh Hyun

PY - 2006/12/31

Y1 - 2006/12/31

N2 - ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR), from β-NAD+. A prototype of mammalian ADPR-cyclases is a lymphocyte antigen CD38. Accumulating evidence indicates that ADPR-cyclases other than CD38 are expressed in various cells and organs. In this study, we discovered a small molecule inhibitor of kidney ADPR-cyclase. This compound inhibited kidney ADPR-cyclase activity but not CD38, spleen, heart or brain ADPR-cyclase activity in vitro. Characterization of the compound in a cell-based system revealed that an extracellular calcium-sensing receptor (CaSR)-mediated cADPR production and a later long-lasting increase in intracellular Ca2+ concentration ([Ca2+]i) in mouse mesangial cells were inhibited by the pre-treatment with this compound. In contrast, the compound did not block CD3/TCR-induced cADPR production and the increase of [Ca2+] i in Jurkat T cells, which express CD38 exclusively. The long-lasting Ca2+ signal generated by both receptors was inhibited by pre-treatment with an antagonistic cADPR derivative, 8-Br-cADPR, indicating that the Ca2+ signal is mediated by the ADPR-cyclse metabolite, cADPR. Moreover, among structurally similar compounds tested, the compound inhibited most potently the cADPR production and Ca2+ signal induced by CaSR. These findings provide evidence for existence of a distinct ADPR-cyclase in the kidney and basis for the development of tissue specific inhibitors.

AB - ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR), from β-NAD+. A prototype of mammalian ADPR-cyclases is a lymphocyte antigen CD38. Accumulating evidence indicates that ADPR-cyclases other than CD38 are expressed in various cells and organs. In this study, we discovered a small molecule inhibitor of kidney ADPR-cyclase. This compound inhibited kidney ADPR-cyclase activity but not CD38, spleen, heart or brain ADPR-cyclase activity in vitro. Characterization of the compound in a cell-based system revealed that an extracellular calcium-sensing receptor (CaSR)-mediated cADPR production and a later long-lasting increase in intracellular Ca2+ concentration ([Ca2+]i) in mouse mesangial cells were inhibited by the pre-treatment with this compound. In contrast, the compound did not block CD3/TCR-induced cADPR production and the increase of [Ca2+] i in Jurkat T cells, which express CD38 exclusively. The long-lasting Ca2+ signal generated by both receptors was inhibited by pre-treatment with an antagonistic cADPR derivative, 8-Br-cADPR, indicating that the Ca2+ signal is mediated by the ADPR-cyclse metabolite, cADPR. Moreover, among structurally similar compounds tested, the compound inhibited most potently the cADPR production and Ca2+ signal induced by CaSR. These findings provide evidence for existence of a distinct ADPR-cyclase in the kidney and basis for the development of tissue specific inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=33846197941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846197941&partnerID=8YFLogxK

M3 - Article

C2 - 17202848

AN - SCOPUS:33846197941

VL - 38

SP - 718

EP - 725

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 6

ER -